Arianit Sherifi
Clinic of Obstetrics and Gynaecology, University Clinical Centre of Kosovo, Kosovo Faculty of Medicine, University of Pristine, Pristine, KosovoPublications
-
Book Review
Expression of PD/PD-L1 as a prognostic biomarker in ovarian serous carcinoma carcinoma - A literature review
Author(s): Astrit M. Gashi, Brikene Elshani*, Hajrullah Latifi, Gent Sopa, Jakup Ismajli and Arianit Sherifi
Ovarian cancer has the highest mortality rate of any gynecologic malignancy other. Even after optimal treatment, the prognosis remains poor. To date, no biomarker can predict the individual outcome of a patient with this disease. Two decades of studies have investigated the prognostic value of PD-1/PD-L1 in high-grade serous ovarian carcinoma; many issues remain unclear, controversial, inconsistent, and often contradictory. PD-L1 is an important immunoregulatory factor and, as a receptor for PD-1, plays an important role in inhibiting the immune response to cancer cells, thus negatively regulating T cell functions. The level of expression in PD-L1 is related to the patient's survival rate and prognosis in various types of cancers, including ovarian cancer, particularly serous ovarian carcinoma. The level of expression in PD-L1 increases the potency of tumour immunogenicity, increa.. Read More»